References
Posner JB: Neuroropic complications of cancer. Philadelphia: EA. Davis. 1995
Twijnstra A, Keyser A, Ongerboer DE, Visser BW (eds): Neurooncology. Primary tumors and neurological complications of cancer. Amsterdam, The Netherlands: Elsevier, 1993
Wiley RG (ed): Neurological complications of cancer. New York: Marcel Dekker. 1995; Neurological disease and therapy
Tikhman AJ, Patchell RA, Morantz RA, Walsh JW (eds): Brain tumors: A comprehensive text. New York: Marcel Dekker. 1995;19, Brain metastases. p. 553–566
Arbit E, Wronski M: The treatment of brain metastases. Neurosurgery Quarterly 5: 1–17, 1995
DeAngelis LM: Management of brain metastases. Cancer Investigation 12(2): 156–165, 1994
O'Neill BP, Buckner JC, Coffey RJ, DiNapoli RP, Shaw EG: Brain metastatic lesions. Mayo Clin Proc 69: 1062–1068, 1994
Mack EE, Gomez EC: Neurotropic melanoma. A case report and review of the literature. J Neurooncol 13: 165–171, 1992
Boogerd W, Voss VW, Hart AAM, Baris G: Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol 15: 165–174, 1993
Gerl A, Clemm C, Kohl P, Schalhorn A, Wilmanns W: Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer. Clin Exp Metastasis 12: 226–230, 1994
Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. Ca Cancer J Clin 45: 8–30, 1995
Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 19: 575–587, 1978
Rojiani AM, Cho E-S, Sharer L, Prineas JW. Electrolyte-induced demyelination in rats. 2. Ultrastructural evolution. Acta Neuropathol (Berl) 88: 293–299, 1994
Arbit E, Lee J, DiResta G: Direct correlation between interstitial fluid pressure and brain edema found in human brain tumors in situ. [Abstract] Ninth International Symposium on Intracranial Pressure 1994
Zhang RD, Price JE, Fujimaki T et al.: Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. Am J Pathol 141: 1115–1124, 1992
Strugar J, Rothbart D, Harrington W, Criscuolo GR: Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81: 560–566, 1994
Ohnishi T, Posner JB, Shapiro WR: Vasogenic brain edema induced by arachidonic acid: Role of extracellular arachidonic acid in blood-brain barrier dysfunction. Neurosurgery 30: 545–551, 1992
Thoron L, Arbit E: Hemostatic changes in patients with brain tumors and systemic malignancy. J Neurooncol 22(2): 87–100, 1994
Tjuvajev J, Uehara H, Desai R et al., Ito S (eds): Intracranial Pressure IX. Tokyo: Springer Verlag; 1994; Corticotropin releasing factor as an alternative treatment of peritumoral brain edema. p. 120–124
Cohen N, Strauss G, Lew R, Silver D, Recht L: Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 6: 1621–1624, 1988
Hung S, Hilsenback S, Feun L: Seizure prophylaxis with phenytoin in patients with brain metastases. [Abstract.] Proc ASCO 10: 327, 1991
Glantz M, Friedberg M, Cole B et al.: Double-blind, randomized, placebo-controlled trial of anticonvulsant prophylaxis in adults with newly diagnosed brain metastases. [Abstract] Proc ASCO 13: 176, 1994
Byrne TN, Cascino TL, Posner JB: Brain metastasis from melanoma. J Neurooncol 1: 313–317, 1983
Heller AJ, Chesterman P, Elwes RDC, Crawford P, Chadwick D, Johnson AL, Reynolds EH: Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised trial. J Neurol Neurosurg Psychiatry 58: 44–50, 1995
Delattre J-Y, Krol G, Thaler HT, Posner JB: Distribution of brain metastases. Arch Neurol 45: 741–744, 1988
Patchell RA, Tibbs PA, Walsh JW et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494–500, 1990
Noordijk EM, Vecht CJ, Haaxma-Reiche H, Padberg GW Voormolen JHC, Hoekstra FH, Tans JTJ, Lambooij N, Metsaars JAL, Wattendorff AR et al.: The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Phys 29: 711–717, 1994
DeAngelis LM, Mandell LIZ, Thaler HT et al.: The role of post-operative radiotherapy after resection of single brain metastases. Neurosurgery 24: 798–865, 1989
Hagen NA, Cirrincione C, Thaler HT et al.: The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 40: 158–160, 1990
Armstrong JG, Wronski M, Galicich J, Arbit E, Leibel SA, Burt M: Postoperative radiation for lung cancer metastatic to the brain. J Clin Oncol 12: 2340–2344, 1994
Alexander EL Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. JNCI 87: 34–40, 1995
Flickinger JC, Kondziolka D, Lunsford LD et al.: A multiinstitutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28: 797–802, 1994
Phillips MIL Stelzer KJ, Griffin TW et al.: Stereotactic radiosurgery: A review and comparison of methods. J Clin Oncol 12: 1085–1099, 1994
Brenner DJ, Hall EJ: One, 10, 20, or 30 fractions in stereotactic radiotherapy for brain malignancies? Response to the correspondence by Drs. Shrieve and Loeffler. Int J Radiat Oncol Biol Phys 30: 501, 1994
Laing RW, Warrington AP, Hines F, Graham JD, Brada M: Fractionated stereotactic external beam radiotherapy in the management of brain metastases. Eur J Cancer 29A(10): 1387–1391, 1993
Shrieve DC, Loeffler JS: Optimal fractionation schedules in small field radiotherapy. Int J Radiat Oncol Biol Phys 30: 497–499, 1994
Davey P, O'Brien P: Disposition of cerebral metastases from malignant melanoma: Implications for radiosurgery. Neurosurgery 28: 8–15, 1991
Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC: Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 79(5): 661–666, 1993
Bernstein M, Laperriere N, Glen J, Leung P, Thomason C, Landon AE: Brachytherapy for recurrent malignant astrocytoma. Int J Radiat Oncol Biol Phys 30: 1213–1217, 1994
Bernstein M, Cabantog A, Laperriere N, Leung P, Thomason C: Brachytherapy for recurrent single brain metastasis. Can J Neurol Sci 22: 13–16, 1995
Shapiro WR, Green S, Burger P et al.: A randomized trial of interstitial radiotherapy (IRT) boost for the treatment of newly diagnosed malignant glioma (glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma, malignant mixed glioma): BTCG Study 8701. [Abstract] Neurology 44: A263, 1994
Valenzuela RF, Hochberg FH, Cosgrove GR et al.: Brachytherapy with a miniature x-ray source in brain metastases. [Abstract] Neurology 44(4): A217, 1994
Boogerd W Dalesio O, Bais EM et al.: Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 69: 972–980, 1992
Rosner D, Nemoto T, Lane WW: Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 58: 832–839, 1986
Green HIM, Smit EF, Haaxma-Reiche H, Postmus PE: Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer. Eur J Cancer [A] 29A: 1696–1699, 1993
Postmus PE, Smit EF, Haaxma-Reiche H, Van Zandwijk N, Ardizzoni A, Quoix E, Kirkpatrick A, Sahmoud T, Giaccone G: Eur Org for Res-Trtmt Cancer Lung Coop. Tenipo-side for brain metastases of small-cell lung cancer: A phase II ntudy. J Clin Oncol 13: 660–665, 1995
Front D, Even-Sapir E, Iositevsky G et al.: Monitoring of 57Co-bleomycin delivery to brain metastases and their tumors of origin. J Neurosurg 67: 506–510, 1987
Siegers HP: Chemotherapy for brain metastases: recent developments and clinical considerations. Cancer Treat Rev 17: 63–76, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Posner, J.B. Brain metastases: 1995. A brief review. J Neuro-Oncol 27, 287–293 (1996). https://doi.org/10.1007/BF00165486
Issue Date:
DOI: https://doi.org/10.1007/BF00165486